Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Explorative Phase IIa Study of VAS203 in Traumatic Brain Injury
2009-012338-56Phase 2Completed
- Sponsor
- Vasopharm
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of ronopterin in traumatic brain injury (TBI), sponsored by Vasopharm. Primary endpoint: Safety endpoints. Started May 2009; status: completed.
02
Drugs
ronopterin
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on 2009-012338-56.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012338-56.